Akero Therapeutics, Inc. (AKRO)
Latest AKRO Insider Trades
Andrew Cheng - OfficerOpen-market sale$1.62M
Timothy Rolph - OfficerOpen-market sale$527K
About Akero Therapeutics, Inc. (AKRO)
Akero Therapeutics, Inc. files with the SEC under CIK 0001744659 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for AKRO in the last 90 days.
AKRO Insider Transactions (Form 4)
7773 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Timothy Rolph - Officer | Option exercise | Common Stock |
AKRO Insider Trading - FAQ
What is the latest insider trade for AKRO?
Akero Therapeutics, Inc. (AKRO) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-09. The full record for AKRO runs to 73 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AKRO stock?
No insider purchases of AKRO were filed in the last 90 days.
How many insiders are selling AKRO stock?
No insider sales of AKRO were filed in the last 90 days. 65 sales are on record for this company.
Where can I see AKRO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks AKRO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AKRO insider buys?
Create a free InsiderAlpha account and press Watch on this page to add AKRO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Tomas J. Heyman view on EDGAR
- - Yuan Xu view on EDGAR
- - Andrew Cheng view on EDGAR
- - Seth Loring Harrison view on EDGAR
- - G. Walmsley Graham view on EDGAR
- - Chou Judy view on EDGAR
- - Timothy Rolph view on EDGAR
- - Mark T. Iwicki view on EDGAR
- - Scott A. Gangloff view on EDGAR
- - William Richard White view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where AKRO's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track AKRO insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
